Tenax Therapeutics (TENX) Research & Development (2010 - 2026)
Tenax Therapeutics (TENX) reported Research & Development of $12.85 million for Q2 2026, up 109.9% from $6.12 million a year earlier and up 11.4% from the prior quarter.
Powered by 
Analysis
Tenax Therapeutics (TENX) Research & Development (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Tenax Therapeutics' Research & Development came in at $45.26 million, up 132.0% year-over-year; for FY2025, it came in at $32.67 million, up 157.1% from FY2024.
- Research & Development has a five-year compound annual growth rate of 48.3% (FY2020 to FY2025).
- By year, Research & Development came in at $12.71 million in FY2024 (+293.6%), $3.23 million in FY2023 (-40.0%), $5.38 million in FY2022 (-78.6%) and $25.15 million in FY2021 (+451.4%).
- The Q2 2026 figure ranks as the highest quarterly Research & Development since Q1 2021.
- Year over year, Research & Development has now increased in each of the last eight quarters, with growth averaging 151.5% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q1 2024 (growth of 907.0%); the low point was Q1 2022 (a decline of 94.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.54 million (Q1 2026), $10.54 million (Q4 2025) and $10.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Tenax Therapeutics | 82.92 Mn | -350.75 Mn | - | 12.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.85 Mn |
| Mar 31, 2026 | 11.54 Mn |
| Dec 31, 2025 | 10.54 Mn |
| Sep 30, 2025 | 10.33 Mn |
| Jun 30, 2025 | 6.12 Mn |
| Mar 31, 2025 | 5.68 Mn |
| Dec 31, 2024 | 4.59 Mn |
| Sep 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | 2.68 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 197,903.00 |
| Mar 31, 2023 | 265,735.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 1.54 Mn |
| Jun 30, 2022 | 1.52 Mn |
| Mar 31, 2022 | 1.18 Mn |
| Dec 31, 2021 | 915,600.00 |
| Sep 30, 2021 | 1.16 Mn |
API Access
Tenax Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=TENX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "TENX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=TENX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();